• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Medical Sciences
  2. Vol 8 (8), 2008
  3. 734-738
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Medical Sciences

Year: 2008 | Volume: 8 | Issue: 8 | Page No.: 734-738
DOI: 10.3923/jms.2008.734.738

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 128

Authors


N. Moslemizadeh

Country: Iran

T.G. Moghadam

Country: Iran

S. Ehteshami

Country: Iran

Keywords


  • Clomiphene citrate
  • tamoxifen citrate
  • estradiol
  • induction of ovulation endometrial thickness
Research Article

Comparison of Clomiphene Citrate Plus Estradiol, with Tamoxifen Citrate Effects in Induction of Ovulation and Pregnancy in Poly Cystic Ovarian Syndrome Patients

N. Moslemizadeh, T.G. Moghadam and S. Ehteshami
The aim of this study was to compare the rates of ovulation and pregnancy after tamoxifen citrate, clomiphene citrate and after adding estradiol (E2) to clomiphene citrate among anovulatory women with infertility. This study was a randomized double blind clinical trial conducted from Aug. 2006 to Aug. 2007 in present Infertility Clinic of Imam Education and Research Hospital, Sari, Iran. The patients were 157 anovulatory women under 35 years of age undergoing ovulation induction. Of total, 144 cases completed the study. They were assigned randomly to receive either tamoxifen citrate or clomiphene citrate on cycle days 3-9 and/or clomiphene citrate on cycle days 3-9 plus E2 on cycle days 8 until all patients undergo HCG injection. Rates of ovulation and pregnancy for the three treatment modalities were measured. Although not statistically significant, the ovulation rates was higher in TAX group compared with clomiphene citrate group or clomiphene citrate plus E2 group (77.1 vs. 60.4 vs. 58.3% p = 0.1). The overall pregnancy rates was significantly higher in women who received tamoxifen citrate compared with those who received clomiphene citrate or clomiphene citrate plus E2 (52.1 vs. 33.3 vs. 22.9%, p = 0.01). This study demonstrated Hormonal supplementation with oral Estradiol following clomiphene citrate therapy in comparison with clomiphene citrate or tamoxifen citrate could not increase ovulation and pregnancy rate.
PDF Fulltext XML References Citation

How to cite this article

N. Moslemizadeh, T.G. Moghadam and S. Ehteshami, 2008. Comparison of Clomiphene Citrate Plus Estradiol, with Tamoxifen Citrate Effects in Induction of Ovulation and Pregnancy in Poly Cystic Ovarian Syndrome Patients. Journal of Medical Sciences, 8: 734-738.

DOI: 10.3923/jms.2008.734.738

URL: https://scialert.net/abstract/?doi=jms.2008.734.738

Related Articles

Comparison of Two Doses of Recombinant Human Chorionic Gonadotropin (rhCG) During Ovulation Induction in Intrauterine Insemination Cycles: A Prospective Randomized Clinical Trial

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved